Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Bristol-Myers Squibb
University Health Network, Toronto
Alliance for Clinical Trials in Oncology
National Institutes of Health Clinical Center (CC)
Eastern Cooperative Oncology Group
NRG Oncology
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Stanford University
Wake Forest University Health Sciences
AstraZeneca
Fondazione del Piemonte per l'Oncologia
Mayo Clinic
Aminex Therapeutics, Inc.
Psyence Australia Pty Ltd
ViroMissile, Inc.
Hummingbird Bioscience
Dana-Farber Cancer Institute
Washington University School of Medicine
University of Florida
Radiopharm Theranostics, Ltd
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
St. Jude Children's Research Hospital
MacroGenics
Daiichi Sankyo
University of Nebraska
Natera, Inc.
Elephas
Innate Pharma
The Netherlands Cancer Institute
OncoNano Medicine, Inc.
Mayo Clinic
Compass Therapeutics
The First Affiliated Hospital of Xinxiang Medical College
University Health Network, Toronto
M.D. Anderson Cancer Center
Strand Therapeutics Inc.
Massive Bio, Inc.
Institut Bergonié
Hadassah Medical Organization
Hadassah Medical Organization
Memgen, Inc.
Medicenna Therapeutics, Inc.
University Health Network, Toronto
Shandong Boan Biotechnology Co., Ltd
UNICANCER
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano